In our first programme of the year, we gathered a group of scientific experts directly involved in analysing the structure and impact of the SARS- Cov-2 coronavirus. There were concerns over the emergence of two new variants, Alpha and Beta, especially whether these variants might spread more quickly, or outmanoeuvre the suite of new vaccines that were about ... Show More
Aug 7
An end to allergic reactions?
As the United States secretary of health and human services, Robert F Kennedy Jr., announces a $500 million cut to mRNA vaccine research in the United States, we hear a statement from the Nobel Prize winning biologist who made mRNA vaccines possible. A team of scientists from Nor ... Show More
29m 37s
Dec 2021
COVID-19 Update: Omicron Variant
Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Record ... Show More
38m 4s
Apr 2020
The Evidence: Young people, lifting lockdowns, USA and Kenya updates
Claudia Hammond and a panel of international experts look at the latest research into Covid-19, the disease caused by the new coronavirus which is sweeping through the world. As the disease spreads, younger people have perhaps not been getting the attention they deserve. How will ... Show More
49m 27s
Dec 2021
The Evidence: When will the pandemic end?
Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ... Show More
50m 9s